Ez a lokalizált összefoglaló bizonyítékokra épülve mutatja be ezt a témát. A teljes tartalom szerkesztőségi egység miatt angol nyelven marad.

BPC-157 vs GHK-Cu: Two Distinct Approaches to Tissue Repair

BPC-157 and GHK-Cu represent two fundamentally different molecular approaches to tissue repair. BPC-157 is a synthetic pentadecapeptide derived from a protective protein in human gastric juice that promotes healing primarily through angiogenesis and growth factor modulation. GHK-Cu is a naturally occurring plasma tripeptide-copper chelate that operates through an entirely different paradigm: reprogramming gene expression across thousands of genes.

Side-by-Side

Different Healing Philosophies: Vascular Supply vs Genetic Reprogramming

BPC-157 operates through an "inside-out" strategy centered on angiogenesis. By upregulating VEGFR2 and activating ERK1/2 signaling, it stimulates new blood vessel formation at injury sites. This is a supply-side intervention — new capillaries deliver oxygen, nutrients, growth factors, and immune cells to damaged tissue, creating the conditions for endogenous repair to function. The breadth of BPC-157's documented preclinical efficacy (gastrointestinal ulcers, tendon, muscle, bone, nerve models) fits this lens: virtually all tissue repair depends on adequate vascular supply. BPC-157 builds the infrastructure.

GHK-Cu takes a radically different approach operating at the genomic level. Connectivity Map studies have shown GHK-Cu affects the expression of over 4,000 human genes (~6% of the human genome). It upregulates genes for collagen synthesis, ECM assembly, antioxidant defense, DNA repair, and stem cell markers, and suppresses genes linked to inflammation, fibrosis, and tissue destruction. The copper ion is not merely structural — it is a cofactor for lysyl oxidase (collagen cross-linking), superoxide dismutase (antioxidant defense), and other copper-dependent enzymes central to tissue maintenance. GHK-Cu rewrites the cellular instruction manual.

When to Use Each

• BPC-157 is the stronger choice when investigating vascularization and blood supply to wound sites, deep-tissue injuries, gastrointestinal lesions, or internal repair where new vessel formation is the rate-limiting factor.
• GHK-Cu is more appropriate for ECM remodeling, collagen architecture, surface-level wound repair, dermal wound healing, scar remodeling, and skin-aging research — plus anywhere copper-dependent enzymatic activation is relevant.

Some protocols investigate both in parallel, targeting different phases of the repair process.

Bottom Line

BPC-157 builds roads; GHK-Cu rewrites the instruction manual. These are not substitutes — they answer different mechanistic questions, operate on different molecular scales, and fit different experimental phases of repair research.

Educational content only. Not medical advice.